Cord Blood Stem Cell Transplantation
"Cord Blood Stem Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transplantation of STEM CELLS collected from the fetal blood remaining in the UMBILICAL CORD and the PLACENTA after delivery. Included are the HEMATOPOIETIC STEM CELLS.
| Descriptor ID |
D036101
|
| MeSH Number(s) |
E02.095.147.500.500.312 E04.936.225.687.312
|
| Concept/Terms |
Cord Blood Stem Cell Transplantation- Cord Blood Stem Cell Transplantation
- Stem Cell Transplantation, Placental Blood
- Umbilical Cord Blood Stem Cell Transplantation
- Placental Blood Stem Cell Transplantation
- Stem Cell Transplantation, Cord Blood
- Blood Stem Cell Transplantation, Umbilical Cord
|
Below are MeSH descriptors whose meaning is more general than "Cord Blood Stem Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Cord Blood Stem Cell Transplantation".
This graph shows the total number of publications written about "Cord Blood Stem Cell Transplantation" by people in this website by year, and whether "Cord Blood Stem Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 14 | 3 | 17 |
| 2018 | 9 | 3 | 12 |
| 2019 | 4 | 0 | 4 |
| 2020 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Cord Blood Stem Cell Transplantation" by people in Profiles.
-
Clinical experience on umbilical cord mesenchymal stem cell treatment in 210 severe and critical COVID-19 cases in Turkey. Stem Cell Rev Rep. 2021 10; 17(5):1917-1925.
-
Human Umbilical Cord Mesenchymal Stromal Cell Treatment of Severe COVID-19 Patients: A 3-Month Follow-Up Study Following Hospital Discharge. Stem Cells Dev. 2021 08 01; 30(15):773-781.
-
Current Status and Future Prospects of Perinatal Stem Cells. Genes (Basel). 2020 12 23; 12(1).
-
Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry ice. J Transl Med. 2020 11 30; 18(1):451.
-
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial. Signal Transduct Target Ther. 2020 08 27; 5(1):172.
-
Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: A case report. Medicine (Baltimore). 2020 Jul 31; 99(31):e21429.
-
Umbilical cord blood therapy to prevent progression of COVID-19 related pneumonia: a structured summary of a study protocol for a pilot randomised controlled trial. Trials. 2020 Jun 04; 21(1):474.
-
Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use. Pain Physician. 2020 03; 23(2):E71-E83.
-
Myeloablative Unrelated Cord Blood Transplantation in Adolescents and Young Adults with Acute Leukemia. Biol Blood Marrow Transplant. 2019 12; 25(12):2438-2446.
-
Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT. Bone Marrow Transplant. 2019 12; 54(12):1987-1994.